Daiichi Sankyo Co Ltd
कार्डियोवास्कुलर और ऑन्कोलॉजी दवाओं का उत्पादन करने वाली नवोन्मेषी दवा कंपनी; एस्ट्रा के साथ साझेदारी...
कार्डियोवास्कुलर और ऑन्कोलॉजी दवाओं का उत्पादन करने वाली नवोन्मेषी दवा कंपनी; एंटीबॉडी-ड्रग कंजुगेट्स पर एस्ट्राजेनेका के साथ साझेदारी।
- Type
- Manufacturer
- Location
- Tokyo, Japan
- Founded
- 2005
- Website
- daiichisankyo.com
- Categories
- चिकित्सा एवं स्वास्थ्य देखभाल आपूर्तियाँ
- Markets
- जापान, संयुक्त राज्य, जर्मनी, फ़्रांस, यूनाइटेड किंगडम
Verified facts
- web-presence-since (green), checked 2026-08-02 Internet Archive (Wayback)
- domain-registered (green), checked 2026-08-08 Domain registry record
- debarment-clear (green), checked 2026-08-08 OpenSanctions
- sanctions-clear (green), checked 2026-08-08 OpenSanctions
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
- gmp-certified (green), checked 2025-12-18 EudraGMDP, EU register of GMP certificates (EMA)
Claimed certifications
- Good Manufacturing Practice
- FDA Registered FDA Establishment Registration
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)